In a letter to the Massachusetts Health Policy Commission, state Attorney General (AG) Maura Healey voiced concerns about the proposed merger between Boston-based Beth Israel Deaconess Medical Center, Burlington, Massachusetts-based Lahey Health and three other healthcare organizations, according to a report from The Boston Globe.
Ms. Healey wrote in her letter that the merger, which would create the second largest health system by revenue in Massachusetts after Boston-based Partners HealthCare, could cause healthcare costs to increase, limit access to care and destabilize independent hospitals, according to the report.
The Commission is responsible for producing an analysis of how the deal will affect costs, quality and access, but it does not have power to block the merger. Ms. Healey does have the authority to do so, however. Her concerns are the first from a state official. The merger was approved by the Massachusetts Department of Public Health in March and the Public Health Council in April. The deal is still pending approval from Ms. Healey and the federal government, according to The Boston Globe.
The AG’s office told The Boston Globe it plans to discuss the deal with executives from Beth Israel Deaconess and Lahey Health. The report suggests Ms. Healey’s office could seek to limit the merger or add other parameters related to pricing or patient mix to help address her concerns.
Full Content: Boston Globe
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Caroline Ellison Seeks Leniency After FTX Fraud Cooperation
Sep 11, 2024 by
CPI
UK Competition Watchdog to Investigate Carlsberg’s £3.3bn Takeover of Britvic
Sep 11, 2024 by
CPI
News Corp Faced Millions in Losses by Moving Away from Google Ads, Ex-Executive Testifies
Sep 10, 2024 by
CPI
EU Faces Critical Innovation Gap, Draghi Report Urges Antitrust Reforms
Sep 10, 2024 by
CPI
Womble Bond Dickinson and Lewis Roca to Merge, Forming 1,300-Lawyer Firm
Sep 10, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Canada & Mexico
Sep 3, 2024 by
CPI
Competitive Convergence: Mexico’s 30-Year Quest for Antitrust Parity with its Northern Neighbor
Sep 3, 2024 by
CPI
Competition and Digital Markets in North America: A Comparative Study of Antitrust Investigations in Mexico and the United States
Sep 3, 2024 by
CPI
Recent Antitrust Development in Mexico: COFECE’s Preliminary Report on Amazon and Mercado Libre
Sep 3, 2024 by
CPI
The Cost of Making COFECE Disappear
Sep 3, 2024 by
CPI